BlackRock Updates Passive Stake in Innoviva Inc. (SC 13G/A)
Ticker: INVA · Form: SC 13G/A · Filed: Jan 22, 2024 · CIK: 1080014
| Field | Detail |
|---|---|
| Company | Innoviva, INC. (INVA) |
| Form Type | SC 13G/A |
| Filed Date | Jan 22, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**BlackRock just updated its Innoviva Inc. holdings, showing continued passive investment.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on January 22, 2024, indicating its ownership of Innoviva Inc. common stock as of December 31, 2023. This filing, Amendment No. 3, updates previous disclosures about BlackRock's passive investment in the pharmaceutical company. This matters to investors because BlackRock is a major institutional investor, and changes in its holdings can signal shifts in confidence or investment strategy, potentially influencing other investors' perceptions of Innoviva Inc.'s stock.
Why It Matters
This filing shows BlackRock's continued, albeit passive, interest in Innoviva Inc., which can provide a degree of stability and institutional backing for the stock.
Risk Assessment
Risk Level: low — This is a routine update from a large institutional investor, indicating a passive stake, which generally poses low risk.
Analyst Insight
An investor should note BlackRock's continued passive stake in Innoviva Inc. as a sign of institutional presence, but should not interpret this routine update as a signal for immediate buying or selling without further analysis of BlackRock's specific percentage ownership (which is not detailed in this excerpt) or Innoviva's fundamentals.
Key Players & Entities
- BlackRock Inc. (company) — the institutional investor filing the SC 13G/A
- Innoviva Inc. (company) — the subject company whose common stock is being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 22, 2024 (date) — the filing date of the SC 13G/A
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as indicated by 'FORM TYPE: SC 13G/A' and 'Amendment No: 3'.
Who is the subject company of this filing?
The subject company is Innoviva Inc., as stated under 'SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Innoviva, Inc.'.
Who is the entity that filed this SC 13G/A?
The entity that filed this SC 13G/A is BlackRock Inc., as stated under 'FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock Inc.'.
What was the 'Date of Event Which Requires Filing of this Statement'?
The 'Date of Event Which Requires Filing of this Statement' was December 31, 2023.
Under which rule was this Schedule 13G filed?
This Schedule 13G was filed under Rule 13d-1(b), as indicated by '[X] Rule 13d-1(b)'.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 22, 2024 regarding Innoviva, Inc. (INVA).